Acta Scientific Clinical Case Reports

Research ArticleVolume 3 Issue 2

Statistical Data from Real-life Observation of Vitamin D Level in Patients in Greece with SARS-CoV-2 Infection

Mouchsiadis Ntemis* and Chatzigeorgiou Charalampos

Department of Reumatology, First General Hospital of Thessaloniki , Greece

*Corresponding Author: Mouchsiadis Ntemis, Department of Reumatology, First General Hospital of Thessaloniki , Greece.

Received: December 18, 2021; Published: January 06, 2022

Abstract

WHO declared SARS-CoV-2 in 2019 a global pandemic. The present aim was to show the prevalence of vitamin D in patients in Greece via real-life data and observation and to compare it with mean levels of vitamin D of general population of same age group.

Methodology: We studied 368 patients with Sars-CoV-2 infection who had been treated in GHT<Ayios Pavlos> during periods (November 2020-February 2021 and November 2021). The mean age was 55 years old (±5). The study ensured the patients' anonymity and was performed in accordance with the national legislation on the use of clinical data for research purposes. In our study, serum 25-(OH) D was measured using the Elecsys® Vitamin D Assay, an electrochemiluminescence binding assay (ECLIA) for the in-vitro determination of total 25-(OH)D (Roche).

Result: Despite Greece is the one of the sunniest countries in Europe there is a paradox, so called Mediterranean, with low mean levels of vitamin D (= 25.08 ng/ml or 62.4 nmol/L) [1].

Keywords: COVID-19; SARS-CoV2; Vitamin D; Calcitriol

Bibliography

  1. S Ksidas., et al. “45th Greek national Congress of Endocrinology, Metabolic Diseases and Diabetes Mellitus”.
  2. Cannell JJ., et al. “Epidemic influenza and vitamin D”. Epidemiology Infection 356 (2006): 1129-1140.
  3. Martineau Adrian R., et al. “Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data”. BMJ 356 (2017): i6583.
  4. Gruber-Bzura BM. “Vitamin D and influenza-prevention or therapy?” International Journal of Molecular Sciences 19 (2018): 2419.
  5. Cui C., et al. “Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system”. Redox Biology 26 (2019): 101295.
  6. Kuka K., et al. “Angiotensin-converting enzyme 2 in lung diseases”. Current Opinion in Pharmacology 6 (2006): 271-276.
  7. Mithal A., et al. “Global vitamin D status and determinants of hypovitaminosis D”. Osteoporosis International 20 (2009): 1807-1820.
  8. Lips P., et al. “Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society”. European Journal of Endocrinology 180 (2019): 23-54.

Citation: Mouchsiadis Ntemis and Chatzigeorgiou Charalampos. “Statistical Data from Real-life Observation of Vitamin D Level in Patients in Greece with SARS-CoV-2 Infection". Acta Scientific Clinical Case Reports 3.2 (2022): 03-05.

Copyright: © 2022 Mouchsiadis Ntemis and Chatzigeorgiou Charalampos. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.